RIVAROXABAN
Generic: RIVAROXABAN
Alembic Pharmaceuticals Inc.Manufacturer
ORALRoute
RIVAROXABANActive Substance
2025-05-14Original Approval
RIVAROXABAN is FDA application ANDA210301, sponsored by ALEMBIC. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
DRUG INTERACTION
1,550 reports
2
DYSPNOEA
1,544 reports
3
OFF LABEL USE
1,353 reports
4
ANAEMIA
1,308 reports
5
DRUG INEFFECTIVE
1,236 reports
6
PULMONARY EMBOLISM
1,080 reports
7
FATIGUE
1,035 reports
8
ATRIAL FIBRILLATION
976 reports
9
GASTROINTESTINAL HAEMORRHAGE
934 reports
10
DIZZINESS
922 reports